Tenon Medical (TNON) Cash from Financing Activities (2021 - 2026)

Tenon Medical's Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $3.9 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 38.22% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $6.6 million (down 58.8% YoY), while the FY2025 annual figure was $9.0 million, down 36.36% from the prior year.
• Cash from Financing Activities was $3.9 million for Q1 2026 at Tenon Medical, up from $2.7 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $14.2 million in Q2 2022 to a low of -$59000.0 in Q2 2025.
• Historically, Cash from Financing Activities has averaged $3.2 million across 5 years, with a median of $1.4 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities jumped 10507.14% in 2024, then slumped 99.39% in 2025.
• A 5-year view of Cash from Financing Activities shows it stood at -$25000.0 in 2022, then jumped by 5584.0% to $1.4 million in 2023, then plunged by 91.76% to $113000.0 in 2024, then soared by 2315.93% to $2.7 million in 2025, then jumped by 41.65% to $3.9 million in 2026.
• The last three Cash from Financing Activities figures came in at $3.9 million (Q1 2026), $2.7 million (Q4 2025), and $59000.0 (Q3 2025), per Business Quant data.